Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin W Bergmann

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Cardiology Journal|March 8, 2018
Optical coherence tomography-guided versus angiography-guided implantation of everolimus-eluting bioresorbable vascular scaffolds: Comparison of coverage, apposition and clinical outcome. The ALSTER-OCT ABSORB registryChristian-Hendrik Heeger, Anne-Sophie Schedifka, Felix Meincke, et al.
Heart Rhythm|February 19, 2022
The ALSTER-FLX Registry: 3-Month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTIONChristina Paitazoglou, Felix Meincke, Martin W Bergmann, et al.
Circulation|May 5, 2005
Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivoChristian Freund, Ruth Schmidt-Ullrich, Anthony Baurand, et al.
EMBO Molecular Medicine|July 7, 2012
Krueppel-like factor 15 regulates Wnt/β-catenin transcription and controls cardiac progenitor cell fate in the postnatal heartClaudia Noack, Maria-Patapia Zafiriou, Hans-Joerg Schaeffer, et al.
Cardiovascular Research|July 22, 2009
NF-kappaB activation is required for adaptive cardiac hypertrophyLaura Zelarayan, Anke Renger, Claudia Noack, et al.
JACC. Cardiovascular Interventions|February 25, 2012
No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) RegistryIbrahim Akin, Ralph Tölg, Matthias Hochadel, et al.
Endocrinology|April 16, 2014
Genetic background defines the regulation of postnatal cardiac growth by 17β-estradiol through a β-catenin mechanismGeorgios Kararigas, Ba Tiep Nguyen, Laura C Zelarayan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 28, 2019
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fractionChristina Paitazoglou, Ramazan Özdemir, Roman Pfister, et al.
Stem Cells (Dayton, Ohio)|January 24, 2013
The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating β-catenin-dependent transcriptionAnke Renger, Maria-Patapia Zafiriou, Claudia Noack, et al.
The Journal of Invasive Cardiology|May 1, 2021
The ALSTER-TAVI All-Comers Registry: Procedural and 1-Year Clinical Outcomes of Balloon-Expandable vs Self-Expanding Contemporary TAVI ValvesChristina Paitazoglou, Felix Meincke, Thorsten Hanke, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Cardiology Journal|March 8, 2018
Optical coherence tomography-guided versus angiography-guided implantation of everolimus-eluting bioresorbable vascular scaffolds: Comparison of coverage, apposition and clinical outcome. The ALSTER-OCT ABSORB registryChristian-Hendrik Heeger, Anne-Sophie Schedifka, Felix Meincke, et al.
Heart Rhythm|February 19, 2022
The ALSTER-FLX Registry: 3-Month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTIONChristina Paitazoglou, Felix Meincke, Martin W Bergmann, et al.
Circulation|May 5, 2005
Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivoChristian Freund, Ruth Schmidt-Ullrich, Anthony Baurand, et al.
EMBO Molecular Medicine|July 7, 2012
Krueppel-like factor 15 regulates Wnt/β-catenin transcription and controls cardiac progenitor cell fate in the postnatal heartClaudia Noack, Maria-Patapia Zafiriou, Hans-Joerg Schaeffer, et al.
Cardiovascular Research|July 22, 2009
NF-kappaB activation is required for adaptive cardiac hypertrophyLaura Zelarayan, Anke Renger, Claudia Noack, et al.
JACC. Cardiovascular Interventions|February 25, 2012
No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) RegistryIbrahim Akin, Ralph Tölg, Matthias Hochadel, et al.
Endocrinology|April 16, 2014
Genetic background defines the regulation of postnatal cardiac growth by 17β-estradiol through a β-catenin mechanismGeorgios Kararigas, Ba Tiep Nguyen, Laura C Zelarayan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 28, 2019
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fractionChristina Paitazoglou, Ramazan Özdemir, Roman Pfister, et al.
Stem Cells (Dayton, Ohio)|January 24, 2013
The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating β-catenin-dependent transcriptionAnke Renger, Maria-Patapia Zafiriou, Claudia Noack, et al.
The Journal of Invasive Cardiology|May 1, 2021
The ALSTER-TAVI All-Comers Registry: Procedural and 1-Year Clinical Outcomes of Balloon-Expandable vs Self-Expanding Contemporary TAVI ValvesChristina Paitazoglou, Felix Meincke, Thorsten Hanke, et al.
Pageof 10